Blog
Rethinking Life Sciences Commercialization for 2026: What’s Working, What’s Not and What’s Next
Learn findings from our Commercialization That Works research and hear from industry leaders and Beghou experts about how organizations are...
Research premiere for ‘Commercialization that Works’; direct channels reignite pharma’s patient-centricity hopes
How AI can keep life sciences innovation moving despite funding and staffing cuts
How to confront biopharma's crisis of cohesion
The new pharma equation: How DTP, DTC, and DTE are re-wiring healthcare around patients
How to make cell and gene therapy commercialization work with Rita Johnson-Greene
Introducing Beghou Arc™: Redefining life sciences commercialization
How to make cell and gene therapy commercialization work
.png?width=400&height=250&name=Blog%20(6).png)
How pharma marketers can prepare for Trump’s 200% tariff threat
Initial CGT launches faltered. The next wave doesn’t have to.
